Vanda Pharmaceuticals
VNDA
VNDA
168 hedge funds and large institutions have $704M invested in Vanda Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 78 increasing their positions, 44 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
7% less capital invested
Capital invested by funds: $759M → $704M (-$55.4M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
70% less call options, than puts
Call options by funds: $378K | Put options by funds: $1.27M
Holders
168
Holding in Top 10
1
Calls
$378K
Puts
$1.27M
Top Buyers
| 1 | +$9.73M | |
| 2 | +$8.39M | |
| 3 | +$5.72M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$5.66M |
| 5 |
AC
Armistice Capital
New York
|
+$5.44M |
Top Sellers
| 1 | -$51.1M | |
| 2 | -$18.9M | |
| 3 | -$9M | |
| 4 |
PAI
Palo Alto Investors
Palo Alto,
California
|
-$6.6M |
| 5 |
GT
Glenmede Trust
Philadelphia,
Pennsylvania
|
-$5.93M |